Saffron Molecule May Fight Liver Cancer: Study

42 Shares
EMAIL
PRINT
COMMENTS
Saffron Molecule May Fight Liver Cancer: Study

Sorafenib, a drug that inhibits the growth of new blood vessels, remains the only available therapy of hepatocellular carcinoma (HCC), a common type of liver cancer, researchers said.

Dubai:  A biomolecule found in saffron may potentially help treat a common form of liver cancer, a new study has claimed.

Sorafenib, a drug that inhibits the growth of new blood vessels, remains the only available therapy of hepatocellular carcinoma (HCC), a common type of liver cancer, researchers said.

Thus, a novel approach against HCC is essential for a better therapeutic outcome, they said.

Researchers from the United Arab Emirates University examined the chemopreventive action of saffron's main biomolecule, crocin, against chemically-induced liver cancer in rats, and to explore the mechanisms by which crocin employs its anti-tumour effects.

"We investigated the anti-cancer effect of crocin on an experimental carcinogenesis model of liver cancer by studying the anti-oxidant, anti-inflammatory, anti-proliferation, pro-apoptotic activities of crocin in vivo," the researchers said.

"In addition, we provided a network analysis of differentially expressed genes in tissues of animals pre-treated with crocin in comparison to induced-HCC animals' tissues," they said.

To further support the results, in vitro analysis was carried out.

The researchers assessed the effects of crocin on HepG2 cells - a perpetual cell line consisting of human liver carcinoma cells - by treating them with various concentrations of crocin. In addition, they studied the effects of crocin on cell cycle distribution of HepG2 cells.

The researchers demonstrated the anti-proliferative and pro-apoptotic properties of crocin when administrated in induced-HCC model.

Crocin exhibited anti-inflammatory properties where a protein complex NF-kB, among other inflammatory markers, was inhibited.

In vitro analysis confirmed crocin's effect in HepG2 by arresting the cell division, inducing apoptosis and down regulating inflammation.

Network analysis identified NF-kB as a potential regulatory hub, and therefore, a candidate therapeutic drug target.

"Taken together, our findings introduce crocin as a candidate chemopreventive agent against HCC," the researchers said.

Share this story on

42 Shares
ALSO READTriple Talaq Important, Will Hear It During Summer Vacation, Says Supreme Court

................................ Advertisement ................................

................................ Advertisement ................................